Introduction to zonisamide

Epilepsy Research

Volumn 68, Issue SUPPL. 2, 2006, Pages

  Baulac, Michel ^a  

^a SORBONNE UNIVERSITÉ   (France)

Author keywords

Antiepileptic drug; Clinical development; Pharmacodynamics; Pharmacokinetics; Zonisamide

Indexed keywords

CARBAMAZEPINE; PHENOBARBITAL; PHENYTOIN; SULFONAMIDE; TOPIRAMATE; VALPROIC ACID; ZONISAMIDE;

APPETITE DISORDER; ATAXIA; BLOOD TOXICITY; CLINICAL TRIAL; CONFUSION; DEPRESSION; DIPLOPIA; DIZZINESS; DRUG ABSORPTION; DRUG APPROVAL; DRUG BIOAVAILABILITY; DRUG BLOOD LEVEL; DRUG DOSE REGIMEN; DRUG EFFICACY; DRUG ERUPTION; DRUG EXCRETION; DRUG HALF LIFE; DRUG HYPERSENSITIVITY; DRUG INFORMATION; DRUG LABELING; DRUG METABOLISM; DRUG RESEARCH; DRUG SAFETY; DRUG STRUCTURE; DRUG SURVEILLANCE PROGRAM; FOCAL EPILEPSY; GOOD CLINICAL PRACTICE; GRAND MAL EPILEPSY; HUMAN; HYPERTHERMIA; IRRITABILITY; MEMORY DISORDER; MYOCLONUS EPILEPSY; NEPHROLITHIASIS; NEUROTOXICITY; PRIORITY JOURNAL; REVIEW; SIDE EFFECT; SOMNOLENCE; STEADY STATE; STRUCTURE ACTIVITY RELATION; SWEAT GLAND DISEASE; TERATOGENICITY; TREATMENT INDICATION; WEIGHT REDUCTION;

EID: 32644473010     PISSN: 09201211     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eplepsyres.2005.11.004     Document Type: Article

References (48)

1. W.M. Bennett Risk of kidney stones in patients treated with zonisamide Neurology 58 Suppl. 3 2002 298 299 (Abstract)
2. M.J. Brodie, R. Duncan, H. Vespignani, A. Solyom, V. Bitenskyy, and C. Lucas Dose-dependent safety and efficacy of zonisamide: a randomised, double-blind, placebo-controlled study in patients with refractory partial seizures Epilepsia 46 2005 31 41
3. Castillo, S., Schmidt, D.B., White, S., 2000. Oxcarbazepine add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 3, CD002028.
4. Chadwick, D.W., Marson, A.G., 2002. Zonisamide add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 2, CD001416.
5. Chaisewikul, R., Privitera, M.D., Hutton, J.L., Marson, A.G., 2001. Levetiracetam add-on for drug-resistant localization related (partial) epilepsy. The Cochrane Database of Systematic Reviews 1, CD001901.
6. Eisai Inc. Zonegran (zonisamide) package insert, May 2004. Eisai Inc., Teaneck, NJ 07666, USA.
7. Eisai Ltd. Zonegran (zonisamide), March 2005. Summary of Product Characteristics. Eisai Ltd., 3 Shortlands, London W6 8EE, UK.
8. E. Faught, R. Ayala, G.G. Montouris, I.E. Leppik the Zonisamide 922 Trial Group Randomized controlled trial of zonisamide for the treatment of refractory partial-onset seizures Neurology 57 2001 1774 1779
9. S.G. Griffith, and Y. Dai Effect of zonisamide on the pharmacokinetics and pharmacodynamics of a combination ethinyl estradiol-norethindrone oral contraceptive in healthy women Clin. Ther. 26 2004 2056 2065
10. T.R. Henry, I.E. Leppik, R.J. Gumnit, and M. Jacobs Progressive myoclonus epilepsy treated with zonisamide Neurology 38 1988 928 931
11. Jette, N.J., Marson, A.G., Hutton, J.L., 2002. Topiramate add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 3, CD001417.
12. S. Kaneko, M. Okada, T. Hirano, T. Kondo, K. Otani, and Y. Fukushima Carbamazepine and zonisamide increase extracellular dopamine and serotonin levels in vivo, and carbamazepine does not antagonize adenosine effect in vitro: mechanisms of blockade of seizure spread Jpn. J. Psychiatry Neurol. 47 1993 371 373
13. M. Kito, M. Maehara, and K. Watanabe Mechanisms of T-type calcium channel blockade by zonisamide Seizure 5 1996 115 119
14. G.M. Kochak, J.G. Page, R.A. Buchanan, R. Peters, and C.S. Padgett Steady-state pharmacokinetics of zonisamide, an antiepileptic agent for treatment of refractory complex partial seizures J. Clin. Pharmacol. 38 1998 166 171
15. S.V. Kothare, I. Valencia, D.S. Khurana, H. Hardison, J.J. Melvin, and A. Legido Efficacy and tolerability of zonisamide in juvenile myoclonic epilepsy Epileptic Disord. 6 2004 267 270
16. M. Kyllerman, and E. Ben-Menachem Zonisamide for progressive myoclonus epilepsy: long-term observations in seven patients Epilepsy Res. 29 1998 109 114
17. Leach, J.P., Marson, A.G., Hutton, J.L., 2002. Remacemide for drug-resistant localization related epilepsy. The Cochrane Database of Systematic Reviews 4, CD001900.
18. B.I. Lee Adverse effects R.H. Levy R.H. Mattson B.S. Meldrum E. Perucca Antiepileptic Drugs fifth ed. 2002 Lippincott Williams & Wilkins Philadelphia 892 898
19. R.H. Levy, I. Ragueneau-Majlessi, W.R. Garnett, M. Schmerler, W. Rosenfeld, J. Shah, and W.J. Pan Lack of a clinically significant effect of zonisamide on phenytoin steady-state pharmacokinetics in patients with epilepsy J. Clin. Pharmacol. 44 2004 1230 1234
20. R.H. Levy, I. Ragueneau-Majlessi, M.J. Brodie, D.F. Smith, J. Shah, and W.J. Pan Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy Ther. Drug Monit. 27 2005 193 198
21. T.E. Lotze, and A.A. Wilfong Zonisamide treatment for symptomatic infantile spasms Neurology 62 2004 296 298
22. R.L. Macdonald Zonisamide: mechanisms of action R. Levy R. Mattson B. Meldrum E. Perucca Antiepileptic Drugs fifth ed. 2002 Lippincott, Williams & Wilkins Healthcare Philadelphia 867 872
23. Y. Masuda, and T. Karasawa Inhibitory effect of zonisamide on human carbonic anhydrase in vitro Arzneimittelforschung 43 1993 416 418
24. Marson, A.G., Kadir, Z.A., Hutton, J.L., Chadwick, D.W., 2000. Gabapentin add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 3, CD001415.
25. M.J. McLean, and R.L. Macdonald Multiple actions of phenytoin on mouse spinal cord neurons in cell culture J. Pharmacol. Exp. Ther. 227 1983 779 789
26. M.J. McLean, and R.L. Macdonald Carbamazepine and 10,11- epoxycarbamazepine produce use- and voltage-dependent limitation of rapidly firing action potentials of mouse central neurons in cell culture J. Pharmacol. Exp. Ther. 238 1986 727 738
27. M.J. McLean, and R.L. Macdonald Sodium valproate, but not ethosuximide, produces use- and voltage-dependent limitation of high frequency repetitive firing of action potentials of mouse central neurons in cell culture J. Pharmacol. Exp. Ther. 237 1986 1001 1011
28. T. Mimaki, Y. Suzuki, T. Tagawa, T. Karasawa, and H. Yabuuchi [3H]zonisamide binding in rat brain Med. J. Osaka Univ. 39 1990 19 22
29. 2+, K+, carbamazepine and zonisamide on hippocampal extracellular glutamate monitored with a microdialysis electrode Br. J. Pharmacol. 124 1998 1277 1285
30. P.N. Patsalos, and E. Perucca Clinically important drug interactions in epilepsy: general features and interactions between antiepileptic drugs Lancet Neurol. 2 2003 347 356
31. Pereira, J., Marson, A.G., Hutton J.L., 2002. Tiagabine add-on for drug-resistant partial epilepsy. The Cochrane Database Systematic Reviews 3, CD001908.
32. Ramaratnam, S., Marson, A.G., Baker, G.A., 2001. Lamotrigine add-on for drug-resistant partial epilepsy. The Cochrane Database of Systematic Reviews 3, CD001909.
33. I. Ragueneau-Majlessi, R.H. Levy, D. Bergen, W. Garnett, W. Rosenfeld, G. Mather, J. Shah, and J.S. Grundy Carbamazepine pharmacokinetics are not affected by zonisamide: in vitro mechanistic study and in vivo clinical study in epileptic patients Epilepsy Res. 62 2004 1 11
34. I. Ragueneau-Majlessi, R.H. Levy, M. Brodie, D. Smith, J. Shah, and J.S. Grundy Lack of pharmacokinetic interactions between steady-state zonisamide and valproic acid in patients with epilepsy Clin. Pharmacokinet. 44 2005 517 523
35. D.M. Rock, R.L. Macdonald, and C.P. Taylor Blockade of sustained repetitive action potentials in cultured spinal cord neurons by zonisamide (AD 810, CI 912), a novel anticonvulsant Epilepsy Res. 3 1989 138 143
36. J.C. Sackellares, R.E. Ramsay, B.J. Wilder, T.R. Browne, and M.K. Shellenberger Randomized, controlled clinical trial of zonisamide as adjunctive treatment for refractory partial seizures Epilepsia 45 2004 610 617
37. C.L. Schauf Zonisamide enhances slow sodium inactivation in Myxicola. Brain Res. 413 1987 185 188
38. D. Schmidt, R. Jacob, P. Loiseau, E. Deisenhammer, D. Klinger, A. Despland, M. Egli, G. Bauer, E. Stenzel, and V. Blankenhorn Zonisamide for add-on treatment of refractory partial epilepsy: a European double-blind trial Epilepsy Res. 15 1993 67 73
39. M. Seino Review of zonisamide development in Japan Seizure 13 Suppl. 1 2004 2 4
40. J. Shah, K. Shellenberger, and D.M. Canafax Zonisamide: chemistry, biotransformation, and pharmacokinetics R. Levy R. Mattson B. Meldrum E. Perucca Antiepileptic Drugs fifth ed. 2002 Lippincott, Williams & Wilkins Healthcare Philadelphia 873 879
41. B.L. Strom, R. Schinnar, A.J. Apter, D.J. Margolis, E. Lautenbach, S. Hennessy, W.B. Bilker, and D. Pettitt Absence of cross-reactivity between sulfonamide antibiotics and sulfonamide nonantibiotics N. Engl. J. Med. 349 2003 1628 1635
42. S. Suzuki, K. Kawakami, S. Nishimura, Y. Watanabe, K. Yagi, M. Seino, and K. Miyamoto Zonisamide blocks T-type calcium channel in cultured neurons of rat cerebral cortex Epilepsy Res. 12 1992 21 27
43. Y. Ueda, T. Doi, J. Tokumaru, and L.J. Willmore Effect of zonisamide on molecular regulation of glutamate and GABA transporter proteins during epileptogenesis in rats with hippocampal seizures Brain Res. Mol. Brain Res. 116 2003 1 6
44. E.A. Wilson, M.J. Brodie, D. Dunkley, J. Shah, and W.-J. Pan Lack of pharmacokinetic interaction between steady-state zonisamide and lamotrigine in patients with epilepsy Poster presented at 9th European Conference on Epilepsy and Society, March 18-20 Malta 2004
45. K. Yagi Overview of Japanese experience-controlled and uncontrolled trials Seizure 13 Suppl. 1 2004 11 15 (discussion 16)
46. S. Yanai, T. Hanai, and O. Narazaki Treatment of infantile spasms with zonisamide Brain Dev. 21 1999 157 161
47. I. Yoshimura, S. Kaneko, N. Yoshimura, and T. Murakami Long-term observations of two siblings with Lafora disease treated with zonisamide Epilepsy Res. 46 2001 283 287
48. W.J. Zhu, and M.A. Rogawski Zonisamide depresses excitatory synaptic transmission by a presynaptic action Epilepsia 40 Suppl. 7 1999 245